1. Long CJ, Canter DJ, Kutikov A, Li T, Simhan J, Smaldone M, et al. Partial nephrectomy for renal masses≥ 7 cm: Technical, oncological and functional outcomes. BJU Int. 2012;109(10):1450–6. 10.1111/j.1464-410X.2011.10608.x

2. Parsons JK, Schoenberg MS, and Carter HB. Incidental renal tumors: Casting doubt on the efficacy of early intervention. Urology. 2001;57(6):1013–5. 10.1016/s0090-4295(01)00991-8

3. Huang WC, Elkin EB, Levey AS, Jang TL, and Russo P. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors—is there a difference in mortality and cardiovascular outcomes? J Urol. 2009;181(1):55–62. 10.1016/j.juro.2008.09.017

4. Russo P, and Huang W. The medical and oncological rationale for partial nephrectomy for the treatment of T1 renal cortical tumors. Urol Clin North Am. 2008;35(4):635–43. 10.1016/j.ucl.2008.07.008

5. Ljungberg B, Hanbury DC, Kuczyk MA, Merseburger AS, Mulders PF, Patard J-J, et al. Renal cell carcinoma guideline. Eur Urol. 2007;51(6):1502–10. 10.1016/j.eururo.2007.03.035

6. Oh JJ, Byun SS, Lee SE, Hong SK, Lee ES, Kim HH, et al. Partial nephrectomy versus radical nephrectomy for non-metastatic pathological T3a renal cell carcinoma: A multi-institutional comparative analysis. Int J Urol. 2014;21(4):352–7. 10.1111/iju.12283

7. Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, et al. European Association of Urology Guidelines on renal cell carcinoma: The 2022 update. Eur Urol. 2022;82(4):399–410. 10.1016/j.eururo.2022.03.006

8. MacLennan S, Imamura M, Lapitan MC, Omar MI, Lam TB, Hilvano-Cabungcal AM, et al. Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur Urol. 2012;61(5):972–93. 10.1016/j.eururo.2012.02.039

9. Sprenkle PC, Power N, Ghoneim T, Touijer KA, Dalbagni G, Russo P, et al. Comparison of open and minimally invasive partial nephrectomy for renal tumors 4–7 centimeters. Eur Urol. 2012;61(3):593–9. 10.1016/j.eururo.2011.11.040

10. Badalato GM, Kates M, Wisnivesky JP, Choudhury AR, and McKiernan JM. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: A propensity scoring approach. BJU Int. 2012;109(10):1457–62. 10.1111/j.1464-410X.2011.10597.x

11. Bertolo R, Autorino R, Simone G, Derweesh I, Garisto JD, Minervini A, et al. Outcomes of robot-assisted partial nephrectomy for clinical T2 renal tumors: A multicenter analysis (ROSULA Collaborative Group). Eur Urol. 2018;74(2):226–32. 10.1016/j.eururo.2018.05.004

12. Bradshaw AW, Autorino R, Simone G, Yang B, Uzzo RG, Porpiglia F, et al. Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: A propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group. BJU Int. 2020;126(1):114–23. 10.1111/bju.15064

13. Amparore D, Pecoraro A, Piramide F, Checcucci E, S DEC, Volpi G, et al. Comparison between minimally-invasive partial and radical nephrectomy for the treatment of clinical T2 renal masses: results of a 10-year study in a tertiary care center. Minerva Urol Nephrol. 2021;73(4):509–17. 10.23736/S2724-6051.21.04390-1

14. Warren AY, and Harrison D. WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: Standards and controversies. World J Urol. 2018;36(12):1913–26. 10.1007/s00345-018-2447-8

15. Dhanji S, Wang L, Liu F, Meagher MF, Saidian A, and Derweesh IH. Recent advances in the management of localized and locally advanced renal cell carcinoma: A narrative review. Res Rep Urol. 2023:99–108. 10.2147/RRU.S326987

16. Dey S, Hamilton Z, Noyes SL, Tobert CM, Keeley J, Derweesh IH, et al. Chronic kidney disease is more common in locally advanced renal cell carcinoma. Urology. 2017;105:101–7. 10.1016/j.urology.2017.03.033

17. Andrade HS, Zargar H, Akca O, Kara O, Caputo PA, Ramirez D. Is robotic partial nephrectomy safe for T3a renal cell carcinoma? Experience of a high-volume center. J Endourol. 2017;31(2):153–7. 10.1089/end.2016.0622

18. Yim K, Aron M, Rha KH, Simone G, Minervini A, Challacombe B, et al. Outcomes of robot-assisted partial nephrectomy for clinical T3a renal masses: A multicenter analysis. Eur Urol Focus. 2021;7(5):1107–14. 10.1016/j.euf.2020.10.011

19. Patel SH, Uzzo RG, Larcher A, Peyronnet B, Lane BR, Pruthi D, et al. Oncologic and functional outcomes of radical and partial nephrectomy in pT3a pathologically upstaged renal cell carcinoma: A multi-institutional analysis. Clin Genitourin Cancer. 2020;18(6):e723–e9. 10.1016/j.clgc.2020.05.002

20. Shvero A, Nativ O, Abu-Ghanem Y, Zilberman D, Zaher B, Levitt M, et al. Oncologic outcomes of partial nephrectomy for stage T3a renal cell cancer. Clin Genitourin Cancer. 2018;16(3):e613–e7. 10.1016/j.clgc.2017.10.016

21. Maurice MJ, Zhu H, Kim S, and Abouassaly R. Survival after partial and radical nephrectomy for high-risk disease: A propensity-matched comparison. Can Urol Assoc J. 2016;10(9–10):E282–e9. 10.5489/cuaj.3707